DCF — CORONA REGIONAL MEDICAL CENTER
Enterprise Value: $-85.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-85.4M
Enterprise Value
$-33.0M
PV of Cash Flows
$-52.5M
PV of Terminal Value
$-84.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $229.8M | $-2.1M | -1.0% | $-11.8M | $-10.7M |
| Year 2 | $236.7M | $0.2M | 0.0% | $-9.8M | $-8.1M |
| Year 3 | $243.8M | $2.7M | 1.0% | $-7.7M | $-5.8M |
| Year 4 | $251.1M | $4.0M | 2.0% | $-6.6M | $-4.5M |
| Year 5 | $258.7M | $4.8M | 2.0% | $-6.2M | $-3.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-85.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$223.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.014075475958531194
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5